314 related articles for article (PubMed ID: 20230536)
1. Variant Creutzfeldt-Jakob disease in a transfusion recipient: coincidence or cause?
Chohan G; Llewelyn C; Mackenzie J; Cousens S; Kennedy A; Will R; Hewitt P
Transfusion; 2010 May; 50(5):1003-6. PubMed ID: 20230536
[TBL] [Abstract][Full Text] [Related]
2. Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study.
Hewitt PE; Llewelyn CA; Mackenzie J; Will RG
Vox Sang; 2006 Oct; 91(3):221-30. PubMed ID: 16958834
[TBL] [Abstract][Full Text] [Related]
3. Lack of evidence of transfusion transmission of Creutzfeldt-Jakob disease in a US surveillance study.
Dorsey K; Zou S; Schonberger LB; Sullivan M; Kessler D; Notari E; Fang CT; Dodd RY
Transfusion; 2009 May; 49(5):977-84. PubMed ID: 19170987
[TBL] [Abstract][Full Text] [Related]
4. Variant CJD and blood transfusion: are there additional cases?
Davidson LR; Llewelyn CA; Mackenzie JM; Hewitt PE; Will RG
Vox Sang; 2014 Oct; 107(3):220-5. PubMed ID: 24916465
[TBL] [Abstract][Full Text] [Related]
5. Transfusion transmission of human prion diseases.
Zou S; Fang CT; Schonberger LB
Transfus Med Rev; 2008 Jan; 22(1):58-69. PubMed ID: 18063192
[TBL] [Abstract][Full Text] [Related]
6. Creutzfeldt-Jakob disease and blood transfusion: updated results of the UK Transfusion Medicine Epidemiology Review Study.
Urwin PJ; Mackenzie JM; Llewelyn CA; Will RG; Hewitt PE
Vox Sang; 2016 May; 110(4):310-6. PubMed ID: 26709606
[TBL] [Abstract][Full Text] [Related]
7. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion.
Llewelyn CA; Hewitt PE; Knight RS; Amar K; Cousens S; Mackenzie J; Will RG
Lancet; 2004 Feb; 363(9407):417-21. PubMed ID: 14962520
[TBL] [Abstract][Full Text] [Related]
8. Prions and transfusion medicine.
Budka H
Vox Sang; 2000; 78 Suppl 2():231-8. PubMed ID: 10938959
[TBL] [Abstract][Full Text] [Related]
9. Ten-year follow-up of two cohorts with an increased risk of variant CJD: donors to individuals who later developed variant CJD and other recipients of these at-risk donors.
Checchi M; Hewitt PE; Bennett P; Ward HJ; Will RG; Mackenzie JM; Sinka K
Vox Sang; 2016 Nov; 111(4):325-332. PubMed ID: 27432362
[TBL] [Abstract][Full Text] [Related]
10. A retrospective case note review of deceased recipients of vCJD-implicated blood transfusions.
Gillies M; Chohan G; Llewelyn CA; MacKenzie J; Ward HJ; Hewitt PE; Will RG
Vox Sang; 2009 Oct; 97(3):211-8. PubMed ID: 19671123
[TBL] [Abstract][Full Text] [Related]
11. Impact of vCJD on blood supply.
Seitz R; von Auer F; Blümel J; Burger R; Buschmann A; Dietz K; Heiden M; Hitzler WE; Klamm H; Kreil T; Kretzschmar H; Nübling M; Offergeld R; Pauli G; Schottstedt V; Volkers P; Zerr I
Biologicals; 2007 Apr; 35(2):79-97. PubMed ID: 17320412
[TBL] [Abstract][Full Text] [Related]
12. Estimation of variant Creutzfeldt-Jakob disease infectivity titers in human blood.
Gregori L; Yang H; Anderson S
Transfusion; 2011 Dec; 51(12):2596-602. PubMed ID: 21645006
[TBL] [Abstract][Full Text] [Related]
13. Managing the risk of transmission of variant Creutzfeldt Jakob disease by blood products.
Ludlam CA; Turner ML
Br J Haematol; 2006 Jan; 132(1):13-24. PubMed ID: 16371015
[TBL] [Abstract][Full Text] [Related]
14. Can prion diseases be transmitted between individuals via blood transfusion: evidence from sheep experiments.
Hunter N; Houston F
Dev Biol (Basel); 2002; 108():93-8. PubMed ID: 12220147
[TBL] [Abstract][Full Text] [Related]
15. ['Variant of Creutzfeldt-Jacob disease and blood transfusion'; report of the Dutch Health Council].
van Aken WG
Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1444-7. PubMed ID: 11503311
[TBL] [Abstract][Full Text] [Related]
16. Dealing with the uncertain risk of variant Creutzfeldt-Jakob disease transmission by coagulation replacement products.
Millar CM; Makris M
Br J Haematol; 2012 Aug; 158(4):442-52. PubMed ID: 22775486
[TBL] [Abstract][Full Text] [Related]
17. An update on the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma products.
Turner ML; Ludlam CA
Br J Haematol; 2009 Jan; 144(1):14-23. PubMed ID: 18950452
[TBL] [Abstract][Full Text] [Related]
18. Strategies to reduce transfusion acquired vCJD.
Wallis JP
Transfus Med; 2011 Feb; 21(1):1-6. PubMed ID: 21070399
[TBL] [Abstract][Full Text] [Related]
19. An overview of prion biology and the role of blood filtration in reducing the risk of transfusion-transmitted variant Creutzfeldt-Jakob disease.
Cervia JS; Sowemimo-Coker SO; Ortolano GA; Wilkins K; Schaffer J; Wortham ST
Transfus Med Rev; 2006 Jul; 20(3):190-206. PubMed ID: 16787827
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of prion filtration of red blood cells to reduce the risk of transfusion-transmitted variant Creutzfeldt-Jakob disease in the Republic of Ireland.
Teljeur C; Flattery M; Harrington P; O'Neill M; Moran PS; Murphy L; Ryan M
Transfusion; 2012 Nov; 52(11):2285-93. PubMed ID: 22486387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
